[Translated article] Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis
Author:
Publisher
Elsevier BV
Subject
Dermatology,Histology,Pathology and Forensic Medicine
Reference30 articles.
1. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited;Fernandez Figueras;J Eur Acad Dermatol Venereol.,2017
2. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation;Berman;J Am Acad Dermatol.,2013
3. Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis;Kim;Cancer Res Treat Off J Korean Cancer Assoc.,2017
4. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis;Blauvelt;N Engl J Med.,2021
5. Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1’s low clinical toxicity;Niu;J Biol Chem.,2019
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells;Archives of Dermatological Research;2024-07-05
2. Line‐field confocal optical coherence tomography shows in vivo apoptosis during a novel treatment for actinic keratosis: A histopathologic controlled study;Journal of the European Academy of Dermatology and Venereology;2024-05-16
3. Tirbanibulin 1% Ointment for Actinic Keratosis: Results from a Real-Life Study;Medicina;2024-01-28
4. Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase‐III trials and the real‐life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022;Journal of the European Academy of Dermatology and Venereology;2023-12-20
5. 1% Tirbanibulin Ointment for Actinic Keratoses on Upper Extremities: A Retrospective Case Review Study;Acta Dermato-Venereologica;2023-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3